# Page 1
Administrative approval for procurement of essential anti-tuberculosis drugs for MDR and XDR TB patients from the subsidy available under the head National Free Diagnosis Services-Free Pathological Services during the financial year 2019-20 under the National Health Mission.
The Government of Maharashtra
the Department of Public Health
Government Resolution No: PRASHAMA-0719/ PR No.450/ Arogya-7
10th Floor, Hospital Building
New Ministry, Mumbai- 400001.
Date is September 13, 2019.
Read: 1) Joint Director, Health Services (Purchase Cell), Directorate of Health Services, Mumbai vide letter No.
Concessions/ Procurement House/ Year 2019-20/ RAA Subsidy/ Procurement of Anti-Tuberculosis Drugs/ Gujarat Tariff Agreement/ PR/ 1984-88/ 2019, dated 29th July, 2019.
Manoj Jhalani, Additional Secretary and Mission Director, National Health Mission, New Delhi. Letters dated 23rd May, 2019 and 01st January, 2019, 04th February, 2019 and 27th February, 2019 issued by Central TB Division, New Delhi.
Letter from Dr. V.S. Salhotra, ADDG (TB), New Delhi, dated 10th June, 2019.
Consent note dated 26th July, 2019 from the Commissioner (Health Services) and Mission Director, National Health Mission, Mumbai.
Preamble: In the Annual Action Plan approved by the Central Government for the financial year 2019-20 under the National Health Mission, a proposal was under consideration of the Government for obtaining administrative approval for procurement of essential anti-tuberculosis drugs for MDR and XDR TB patients at the rate of the subsidy provided under the head National Free Diagnosis Services-Free Pathological Services under the FMR Code 6.4.1.
Government Decision: Under Revised National Tuberculosis Control Programme, Central TB Division, New Delhi is supplying some essential medicines to MDR and XDR TB patients.
# Page 2
Government Resolution No: PRASHAMA-0719/ PR No.450/ Arogya-7
The Central Government has decided to procure these medicines locally till the near future.
National Health Mission (under PIP) available in 2019-20
Purchase from subsidy has been allowed vide letter dated 23rd May, 2019 referred by the Central Government. These drugs are essential for MDR and XDR tuberculosis patients.
Without proper treatment, patients can develop serious complications.
There's a possibility. The government has approved the budget for 2019-20.
The Annual Action Plan under the heading of FMR Code 6.4.1
Diagnosis Services- MDR and XDR from the funds available under Free Pathological Services
An estimated amount of Rs. Rs. 1216.65 lakhs for Anti-Tuberculosis
Gujarat Medical Services Corporation Ltd. (GMSCL) on the rate agreement of
Joint Director, Health Services (Purchase Cell), to get administrative approval for the proposal.
Mumbai is presented.
Accordingly, the total annual MDR and XDR for TB patients in the following statement
Gujarat Medical Services Corporation Ltd. Haffkine Biopharma Citycals Ltd. (GMSCL) on a tariff agreement.
Administrative approval is being granted for the same to be done by the procurement cell at Mumbai subject to the following conditions.
the prospectus
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| Sr. No                 | Name of Medicine                       | Total Rate with GST as per GMSCL RC (In Rs.) as per pack size | Quantity     | Total Amount (In Rs.) |
| Cap. Cycloserine 250mg | 23.325                                 | 3923000                                                       | 91503975.00  |
| 2                      | Inj. Capreomycin 1gm Vial              | 201.60                                                        | 87000        | 17539200.00           |
| 3                      | Cap. Rifabutin 150mg                   | 32.247                                                        | 84000        | 2708748.00            |
| 4                      | Tab. Amoxycillin + Clavulanic Acid 1gm | 7.56                                                          | 481000       | 3636360.00            |
| 5                      | Tab. Pyridoxine 50mg                   | 0.5867                                                        | 3210000      | 1883307.00            |
| 0.5867                 | 7490000                                | 4394383.00                                                    |
| Total                  |                                        |                                                               | 121665973.00 |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Conditions:
1) The number of MDR and XDR tuberculosis patients and the number of patients and the required drugs
The number of doses and the time taken for the supplier to deliver the medicine.
Be sure to buy the medicines carefully.
Page 2 of 5
# Page 3
Government Resolution No: PRASHAMA-0719/ PR No.450/ Arogya-7
Ministry of Health and Family Welfare, Government of India, New Delhi. 01/01/2019, 04/02/2019, 27/02/2019, Dy. 23/05/2019 and D. Action should be taken as per the guidelines issued vide letter 10/06/2019. The requirement/ demand for MDR and XDR TB drugs should be assessed/ verified and purchased accordingly.
3) It should be ensured that the specifications of the said medicines are as prescribed and updated by the Central Government. The technical specifications of the items to be procured should be prepared by the concerned experts (technical committee/ officials) as per the guidelines approved by the Central Government. After that, you have to buy them.
The procurement process should be carried out within the prescribed limits as per the provisions of the revised rule book of procedures for office procurement to be carried out by government departments published under Government Decision, Industry, Energy and Labour Department, No. Bhankhas-2014/ PR No. 82/ Part-III/ Industry-4, dated 1st December, 2016.
5) Pre/ post dispatch random sample inspection of the items to be purchased should be done to ensure that only the items with proper and correct specifications are purchased.
6) Storage and distribution of the items to be procured after supply, supply chain management and inventory management should be done in a proper manner to ensure that these items do not remain unused and are used in a timely manner.
7) The cost of the proposed purchase of the above-mentioned medicines is the year 2019
Under the FMR Code 6.4.1 approved in the PIP of 20, the subsidy under the head National Free Diagnosis Services-Free Pathological Services should be shared.
8) Also, it should be ensured that there is no duplication in the purchase of these items.
The entire responsibility of this will be of the director.
Page 3 of 5
# Page 4
Government Resolution No: PRASHAMA-0719/ PR No.450/ Arogya-7
The Central Vigilance Commission (CVC) guidelines should be strictly followed while carrying out the entire procurement process.
30/ Part- 2/2013/ Regulations, dated 17th April, 2015 in Annexure A No. 4 to the Financial Powers Rules, 1978, Part I, Sub-Section-II, Rule No. 7 in front of No. 6 conditions must be met.
Supply orders should be issued only after the approval of the Purchasing Committee after the completion of the procurement process. In this regard, the Public Health Department, vide Government Resolution No. Procurement should be carried out in accordance with the provisions of the Government Decision 2016/ EC 240/ Health-8, dated July 26, 2017.
The Programme Heads shall ensure that the proposed procurement does not exceed 25% of the annual demand as reported under ASHAAP-T- 18018/04/2018-Part (2) dated 23rd May, 2019 of Additional Secretary& Mission Director (NHM), Government of India, Ministry of Health& Family Welfare, New Delhi.
The Commissioner (Health Services) and Mission Director, National Health Mission, Mumbai, Director (Health Services), Directorate of Health Services, Mumbai, Joint Director, Health Services (Procurement Cell), Directorate of Health Services, Mumbai and the Programme Head shall be solely responsible for ensuring that the above conditions mentioned in Sections 1 to 12 are fulfilled and the procurement of medicines is done as per rules and requirements.
# Page 5